UNS unilife corporation
Add to My Watchlist 0.00% ! 0.5¢

why biotechs need to worry about generics, too, page-4

  1. mpv2
    1,875 Posts.
    lightbulb Created with Sketch. 16
    clock Created with Sketch.
    15/06/11
    21:56
    Post #: 8543817
    well reason gabbie. Why then would the pharma pay a premium for allegly prolonging the life of the patent?
    Is that why the sp is heading down?
    The only thing then uns has for their product is the safety issue. Cost then would be a big factor contributing to the take up.
    UNS Price at posting: 69.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Outstanding Drill Results Define New High-Grade Iris Zone at Apollo Hill
right-arrow Created with Sketch.
NEWS Proteomics International granted first patent for endometriosis diagnostic blood test in Japan
right-arrow Created with Sketch.
ACW Actinogen Confirms 100th Participant in Alzheimer’s Disease Trial and Interim Analysis Timeline
right-arrow Created with Sketch.
NEWS Significant new gold-copper discovery at Minyari Dome delivers high-grade results
right-arrow Created with Sketch.
AFP Combogesic IV Launches in Canada and R&D Shows Significant Advances
right-arrow Created with Sketch.
NEWS Next Science to Sell Majority of Assets in Proposed Transaction
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.